Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (251-260 of 536) with videos related to

Pageof 54
Sort By:
Communications Biology|April 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growthMelissa Valerio, Wenyuan Wei, Hyunjun Kang, et al.
Molecular Pharmaceutics|October 27, 2009
Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemiaYan Jin, Shujun Liu, Bo Yu, et al.
Journal of Cellular Physiology|January 10, 2019
The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AMLLe Xuan Truong Nguyen, Estelle Troadec, Arjun Kalvala, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Targeted Irradiation and STAT3 Inhibition Reprogram the AML Microenvironment and Extend Survival: Toward Translational ImmunoradiotherapySrideshikan Sargur Madabushi, Jamison Brooks, Darren Zuro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 1, 2020
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet S Sandhu, Sanjeet Dadwal, Dongyun Yang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Fever and neutropenia clinical practice guidelinesAlison G Freifeld, Lindsey Robert Baden, Arthur E Brown, et al.
Proteomics|March 3, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemiaXiaodan Su, David M Lucas, Liwen Zhang, et al.
BMC Genomics|November 9, 2012
Methods for high-throughput MethylCap-Seq data analysisBenjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
Science Signaling|April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathwayAnn-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Pageof 54

Showing results (251-260 of 536) with videos related to

Sort By:
Pageof 54
Communications Biology|April 14, 2026
Allosteric inhibition of RAN decreases miR-126 biogenesis in endothelial cells and controls acute myeloid leukemia growthMelissa Valerio, Wenyuan Wei, Hyunjun Kang, et al.
Molecular Pharmaceutics|October 27, 2009
Targeted delivery of antisense oligodeoxynucleotide by transferrin conjugated pH-sensitive lipopolyplex nanoparticles: a novel oligonucleotide-based therapeutic strategy in acute myeloid leukemiaYan Jin, Shujun Liu, Bo Yu, et al.
Journal of Cellular Physiology|January 10, 2019
The Bcl-2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AMLLe Xuan Truong Nguyen, Estelle Troadec, Arjun Kalvala, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
Targeted Irradiation and STAT3 Inhibition Reprogram the AML Microenvironment and Extend Survival: Toward Translational ImmunoradiotherapySrideshikan Sargur Madabushi, Jamison Brooks, Darren Zuro, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 1, 2020
Outcome of Allogeneic Hematopoietic Cell Transplantation after Venetoclax and Hypomethylating Agent Therapy for Acute Myelogenous LeukemiaKaramjeet S Sandhu, Sanjeet Dadwal, Dongyun Yang, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 29, 2009
Fever and neutropenia clinical practice guidelinesAlison G Freifeld, Lindsey Robert Baden, Arthur E Brown, et al.
Proteomics|March 3, 2009
Validation of an LC-MS based approach for profiling histones in chronic lymphocytic leukemiaXiaodan Su, David M Lucas, Liwen Zhang, et al.
BMC Genomics|November 9, 2012
Methods for high-throughput MethylCap-Seq data analysisBenjamin A T Rodriguez, David Frankhouser, Mark Murphy, et al.
The AAPS Journal|March 5, 2016
Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in RodentsHao Cheng, Zhiliang Xie, William P Jones, et al.
Science Signaling|April 17, 2014
Intronic miR-3151 within BAALC drives leukemogenesis by deregulating the TP53 pathwayAnn-Kathrin Eisfeld, Sebastian Schwind, Ravi Patel, et al.
Pageof 54